139 related articles for article (PubMed ID: 31858188)
1. Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma.
Bravo-Perez C; Pajares I; Muiña B; Escobar H; Amigo ML; Garcia-Malo MD; Garcia J; Rodriguez-Pinilla SM; Piris MA; Ortuño FJ
Ann Hematol; 2020 Feb; 99(2):391-393. PubMed ID: 31858188
[No Abstract] [Full Text] [Related]
2. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
Chan TS; Khong PL; Kwong YL
Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
[No Abstract] [Full Text] [Related]
3. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
Gururangan S; Horner M; Rodman JH; Marina NM
Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
[TBL] [Abstract][Full Text] [Related]
4. Histiocytic sarcoma progressing from follicular lymphoma and mimicking acquired hemophagocytic lymphohistiocytosis.
Schünemann C; Göhring G; Behrens YL; Kreipe HH; Ganser A; Thol F
Ann Hematol; 2020 Oct; 99(10):2441-2443. PubMed ID: 32808104
[No Abstract] [Full Text] [Related]
5. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Layden BT; Joseph M; Tallman MS; Platanias LC
Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic features of the biopsied liver at onset of childhood B-precursor acute lymphoblastic leukemia presenting as severe jaundice.
Mori T; Sugita K; Suzuki T; Ishikawa T; Kurosawa H; Matsui A
J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):354-7. PubMed ID: 9285391
[No Abstract] [Full Text] [Related]
7. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
[TBL] [Abstract][Full Text] [Related]
8. Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
Kim TK; Xu ML; Podoltsev NA; Prebet T; Barbarotta L; Amin K; Kasberg S; Roche K; Stahl M; Gore SD; Zeidan AM
Ann Hematol; 2016 Oct; 95(11):1895-8. PubMed ID: 27468851
[No Abstract] [Full Text] [Related]
9. Extraparotidal low grade follicular lymphoma associated with primary Sjögren's syndrome.
Gómez-Rubio J; Bárcena-Atalaya AB; Ruiz-Irastorza G
Med Clin (Barc); 2018 Mar; 150(5):204-205. PubMed ID: 28865918
[No Abstract] [Full Text] [Related]
10. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
Matsuda I; Hirota S
Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
Short NJ; Kantarjian HM; Ko H; Khoury JD; Ravandi F; Thomas DA; Garcia-Manero G; Khouri M; Cortes JE; Wierda WG; Verstovsek S; Estrov Z; Ferrajoli A; Thompson PA; Pierce S; O'Brien SM; Jabbour E
Am J Hematol; 2017 Jun; 92(6):E114-E117. PubMed ID: 28295472
[No Abstract] [Full Text] [Related]
12. Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
Bassan R; Rohatiner AZ; Lerede T; Di Bona E; Rambaldi A; Pogliani E; Rossi G; Fabris P; Morandi S; Casula P; Carter M; Lambertenghi-Deliliers G; Lister TA; Barbui T
Hematol J; 2000; 1(4):226-34. PubMed ID: 11920195
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Jorgensen JL; Cortes J; Faderl S; Garcia-Manero G; Verstovsek S; Koller C; Pierce S; Huh Y; Wierda W; Keating MJ; Kantarjian HM
Blood; 2009 Jun; 113(25):6330-7. PubMed ID: 18703706
[TBL] [Abstract][Full Text] [Related]
14. Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
Chen YC; Ho CL; Kao WY; Hwang JM; Sheu LF; Chao TY
Ann Hematol; 2001 Nov; 80(11):647-52. PubMed ID: 11757723
[TBL] [Abstract][Full Text] [Related]
15. Primary ocular recurrence of leukemia following bone marrow transplant.
Sahdev I; Weinblatt ME; Lester H; Finger PT; Kochen J
Pediatr Hematol Oncol; 1993; 10(3):279-82. PubMed ID: 8217546
[TBL] [Abstract][Full Text] [Related]
16. Secondary prophylaxis of an acute coronary syndrome during rituximab infusion.
Triguero Moreno A; Gual Capllonch F; Sancho Cía JM
Med Clin (Barc); 2020 Jan; 154(2):69-70. PubMed ID: 31178296
[No Abstract] [Full Text] [Related]
17. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
18. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
19. Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma.
Lucijanic M; Jaksic O
Ann Hematol; 2020 Sep; 99(9):2191-2192. PubMed ID: 32556456
[No Abstract] [Full Text] [Related]
20. Adding rituximab to cyclophosphamide, vincristine and prednisone increases time to treatment failure or progression in people with untreated stage III/IV follicular lymphoma.
Ghielmini M
Cancer Treat Rev; 2005 Dec; 31(8):644-7. PubMed ID: 16289339
[No Abstract] [Full Text] [Related]
[Next] [New Search]